Company
Caribou Biosciences ($CRBU)
- Biotech
- Headquarters:
- Berkeley, CA
Description
Develops genome-edited allogeneic CAR-T cell therapies using CRISPR and chRDNA technology for patients with hematologic malignancies and other severe diseases.
Caribou Biosciences ($CRBU) is located in the Silicon Valley ecosystem.
Related
March BiosciencesDevelops clinical-stage CAR-T cell therapies, including MB-105, aimed at difficult hematological cancers, with a focus on relapsed or…
CRISPR Therapeutics ($CRSP)CRISPR Therapeutics develops CRISPR-based gene-editing therapies across hemoglobinopathies, oncology, diabetes, and cardiovascular disease,…
Sangamo Therapeutics ($SGMO)Develops genomic medicines using zinc finger technology for patients with severe diseases where current treatments may offer mainly symptom…
bluebird bioDevelops one-time gene addition treatments for rare hematologic diseases, using patients' own cells and patient support services to help…
Scribe TherapeuticsEngineers CRISPR-based therapeutics by modifying natural CRISPR systems, with treatments focused on cardiometabolic disease and…
Xaira TherapeuticsBuilds an AI-powered drug discovery and development platform to decode disease, design therapies, and support end-to-end medicine creation…
Iovance Biotherapeutics ($IOVA)Develops and manufactures tumor infiltrating lymphocyte therapies that use a patient’s immune cells, serving people with cancer and…
ArsenalBioDevelops in vivo T cell therapies and reprogrammed CAR T approaches for chronic diseases, including cancer and autoimmunity, with focus on…
Legend Biotech ($LEGN)CAR-T cell therapy company behind ciltacabtagene autoleucel and next-generation cell-therapy programs. Public via $LEGN (NASDAQ).
Liquidia ($LQDA)Develops therapies and lung drug-delivery technology for rare cardiopulmonary diseases, including pulmonary arterial hypertension,…
Artiva Biotherapeutics ($ARTV)Develops off-the-shelf, non-genetically modified natural killer cell therapies for deep B-cell depletion, aiming to help patients with…
Altos LabsDevelops medicines based on cell rejuvenation, using computation, machine learning, and internal and external biological data to study cell…